The collaboration here at the University of Missouri to bring this product from MURR, through the research process, and into clinical application is an extraordinary example of our commitment to precision medicine. In 2021, MURR entered into an exclusive multi-year agreement with Advanced Accelerator Applications International, SA (ADACAP), a Novartis company, to provide Lu-177, the key ingredient in Pluvicto and Lutathera, a similar infusion treatment for neuroendocrine tumors
Weeks 25-48+: Continued progress beyond what dual agonists can achieve
Every Human Study, Counted Three studies
Preclinical in vitro studies have shown controversial data regarding the role of the complement system in binding coronaviruses (Santiesteban-Lores et al., 2021)
On the dose-response curve of the effect of intraperitoneal BPC-157 on the flinching response in the formalin test, BPC-157 led to significant suppression of the flinches in a dose-dependent manner in phase 1 but showed little effect in phase 2 (Fig
The half-life of a drug is the time it takes for its concentration in your body to be reduced by half